The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac Surgery
Status:
Unknown status
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
Anemia after cardiac surgery is a vast phenomena. More than 70% of the patients who under
went surgery represented with hemoglobin less than 8 mg/dl (the cutoff for blood transfusion)
and more than 80% of the patients receives at least one unit of red blood cell transfusion.
There were number of attempts to prevent the postoperative anemia by giving erythropoietin,
Iron per os and intra venus iron. non of the above have shown increase in Hemoglobin after
the cardiac surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Rambam Health Care Campus
Collaborators:
Carmel Medical Center The Baruch Padeh Medical Center, Poriya